# Photronics Inc: Form 10-Q for the period ended Jan 31, 2021

- Company: [Photronics Inc](/companies/plab.md) (CIK 810136)
- Form: 10-Q
- Filed: 2021-03-10
- Accepted by EDGAR: Mar 10, 2021, 17:17 ET
- Period: 2021-01-31
- Accession: 0001140361-21-008063
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/810136/000114036121008063/brhc10021438_10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/810136/000114036121008063/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2021-01-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2020-11-01 to 2021-01-31 | $152.1m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2020-11-01 to 2021-01-31 | $121.5m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2020-11-01 to 2021-01-31 | $30.5m | us-gaap:GrossProfit |
| Research and development | 3 months, 2020-11-01 to 2021-01-31 | $4.7m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2020-11-01 to 2021-01-31 | $14.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2020-11-01 to 2021-01-31 | $11.8m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2020-11-01 to 2021-01-31 | $2.9m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2020-11-01 to 2021-01-31 | $8.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2020-11-01 to 2021-01-31 | $0.13 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2020-11-01 to 2021-01-31 | $0.13 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2020-11-01 to 2021-01-31 | 63,005,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2020-11-01 to 2021-01-31 | $26.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2020-11-01 to 2021-01-31 | $17.5m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 3 months, 2020-11-01 to 2021-01-31 | $13.2m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2021-01-31 | $278.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2021-01-31 | $506.1m | us-gaap:AssetsCurrent |
| Total assets | at 2021-01-31 | $1.23bn | us-gaap:Assets |
| Current liabilities | at 2021-01-31 | $145.5m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2021-01-31 | $253.6m | us-gaap:Liabilities |
| Long-term debt | at 2021-01-31 | $80.0m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2021-01-31 | $21.6m | us-gaap:LongTermDebtCurrent |
| Short-term borrowings | at 2021-01-31 | $0 | us-gaap:ShortTermBorrowings |
| Shareholders' equity | at 2021-01-31 | $815.5m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 30,464 characters.

### Overview

Management's discussion and analysis ("MD&A") of the Company's financial condition, results of operations and outlook should be read in conjunction with its condensed consolidated financial statements and related notes. Various segments of this MD&A contain forward-looking statements, all of which are presented based on current expectations, which may be adversely affected by uncertainties and risk factors (presented throughout this filing and in the Company's Annual Report on Form 10-K for fiscal 2020), that may cause actual results to materially differ from these expectations.

We sell substantially all of our photomasks to semiconductor designers and manufacturers, and manufacturers of FPDs. Photomask technology is also being applied to the fabrication of other higher-performance electronic products such as photonics, microelectronic mechanical systems and certain nanotechnology applications. Our selling cycle is tightly interwoven with the development and release of new semiconductor and display designs and applications, particularly as they relate to the semiconductor industry's migration to more advanced product innovation, design methodologies, and fabrication processes. The demand for photomasks primarily depends on design activity rather than sales volumes from products manufactured using photomask technologies. Consequently, an increase in semiconductor or display sales does not necessarily result in a corresponding increase in photomask sales. However, the reduced use of customized ICs, reductions in design complexity, other changes in the technology or methods of manufacturing or designing semiconductors, or a slowdown in the introduction of new semiconductor or display designs could reduce demand for photomasks ‒ even if the demand for semiconductors and displays increases. Advances in semiconductor, display, and photomask design and production methods that shift the burden of achieving device performance away from lithography could also reduce the demand for photomasks. Historically, the microelectronic industry has been volatile, experiencing periodic downturns and slowdowns in design activity. These downturns have been characterized by, among other things, diminished product demand, excess production capacity, and accelerated erosion of selling prices, with a concomitant effect on revenue and profitability.

We are typically required to fulfill customer orders within a short period of time after receipt of an order, sometimes within twenty-four hours. This results in a minimal level of backlog orders, typically one to two weeks of backlog for IC photomasks and two to three weeks of backlog for FPD photomasks.

The global semiconductor and FPD industries are driven by end markets which have been closely tied to consumer-driven applications of high-performance devices, including, but not limited to, mobile display devices, mobile communications, and computing solutions. While we cannot predict the timing of the industry's transition to volume production of next-generation technology nodes, or the timing of up and down-cycles with precise accuracy, we believe that such transitions and cycles will continue into the future, beneficially and adversely affecting our business, financial condition, and operating results as they occur. We believe our ability to remain successful in these environments is dependent upon the achievement of our goals of being a service and technology leader and efficient solutions supplier, which we believe should enable us to continually reinvest in our global infrastructure.

### Recent Developments

In December 2020, we entered into a five-year $35.6 million finance lease for a high-end lithography tool. Monthly payments on the lease, which commenced in January 2021, increase from $0.04 million after the first three months to $0.6 million for the following nine months, followed by forty-eight monthly payments of $0.5 million. As of the due date for the forty-eighth monthly payment, we may exercise an early buy-out option to purchase the tool at 39.84% of its original cost. If we do not exercise the early buy-out option, then at the end of the five-year lease term, at our option, we may return the tool, elect to extend the lease term for a period and a lease payment to be agreed with lessor at the time, or purchase the tool for its then-fair market value as determined by the lessor. Since we are reasonably certain that we will exercise the early buy-out option, we have classified the lease as a finance lease. The interest rate of the lease, which is the rate implicit in the lease, is 1.14%.

In February 2021, we entered into a five-year $7.2 million finance lease for a high-end inspection tool. Monthly payments on the lease, which commenced in February 2021, are $0.1 million per month. Upon the payment of the fiftieth monthly payment and prior to payment of the fifty-first monthly payment, we may exercise an early buy-out option to purchase the tool at 33.684638% of its original cost. If we do not exercise the early buy-out option, then at the end of the five-year lease term, the lease shall continue to renew on a month-to-month basis at the same rental; at our option, after the original term or any renewal periods, we may return the tool, elect to extend the lease, or purchase the tool at its fair market value. Since we are reasonably certain that we will exercise the early buy-out option, we have classified the lease as a finance lease. The interest rate of the lease, which is the rate implicit in the lease, is 1.09%.

In the fourth quarter of fiscal 2020, we were approved to borrow 200 million Chinese renminbi (RMB) (approximately $30.9 million, at the balance sheet date) from the China Construction Bank Corporation. We received initial proceeds of 41 million RMB (approximately $6.3 million, at the balance sheet date) against this approval in November 2020. Please see Note 6 to the condensed consolidated financial statements for additional information on this loan.

In the fourth quarter of fiscal 2020, the Company’s board of directors authorized the repurchase of up to $100 million of its common stock, pursuant to a repurchase plan under Rule 10b5-1 of the Securities Act of 1933 (as amended) (“the Securities Act”). See Note 14 of the condensed consolidated financial statements for additional information on this repurchase program.

In the fourth quarter of fiscal 2020, PDMC, the Company’s majority-owned IC subsidiary in Taiwan, paid a dividend of which 49.99%, or approximately $16.2 million, was paid to noncontrolling interests.

In the first quarter of fiscal 2020, we acquired the remaining 0.2% of noncontrolling interests in Photronics Cheonan, Ltd. (formerly PK, Ltd.), our South Korean subsidiary, for $0.6 million.

In the first quarter of fiscal 2020, we adopted ASU 2016-02 and all subsequent amendments, collectively codified in Accounting Standards Codification Topic 842 - “Leases” (“Topic 842”). This guidance requires modified retrospective adoption, either at the beginning of the earliest period presented or at the beginning of the period of adoption; we elected to apply the guidance at the beginning of the period of adoption, and recognized right-of-use leased assets of $6.5 million and corresponding lease liabilities which were discounted at our incremental borrowing rates, on our November 1, 2019 condensed consolidated balance sheet to reflect our adoption of the guidance. Our adoption of Topic 842 did not affect our cash flows or our ability to comply with covenants under our credit agreements.

In the fourth quarter of fiscal 2019, our board of directors declared a dividend of one preferred stock purchase right (a “Right”), payable on or about October 1, 2019, for each share of common stock, par value $0.01 per share, of the Company outstanding on September 30, 2019, to the stockholders of record on that date. In connection with the distribution of the Rights, we entered into a Section 382 Rights Agreement (the “Rights Agreement”), dated as of September 23, 2019, between the Company and Computershare Trust Company, N.A., a federally chartered trust company, as rights agent. The purpose of the Rights Agreement is to deter trading of our common stock that would result in a change in control (as defined in Internal Revenue Code Section 382), thereby preserving our future ability to use our historical federal net operating losses and other Tax Attributes (as defined in the Rights Agreement). Each Right entitles the registered holder to purchase from the Company one one-thousandth of a share of Series A Preferred Stock, par value $0.01 per share, at a price of $33.63, subject to adjustment. The Rights, which are described in the Company’s Current Report on Form 8-K filed on September 24, 2019, are in all respects subject to and governed by the provisions of the Rights Agreement. The Rights will expire at the earliest to occur of (i) the close of business on the day following the date on which our board of directors determines, in its sole discretion, that the Rights Agreement is no longer necessary for the preservation of material valuable tax attributes, or the tax attributes have been fully utilized and may no longer be carried forward or (ii) the close of business on September 22, 2022.

In the fourth quarter of fiscal 2019, PDMC, the Company’s majority-owned IC subsidiary in Taiwan, paid a dividend of which 49.99%, or approximately $18.9 million, was paid to noncontrolling interests.

In the fourth quarter of fiscal 2019, upon our request, a financing entity made an advance payment of $3.5 million to an equipment vendor. We entered into a Master Lease Agreement (“MLA”) with this financing entity, which became effective in July 2019. The MLA enables us to request advance payments or other funds to finance equipment to be leased or purchased in the U.S. In connection with this MLA, we have been approved for financing of $35 million for the purchase of a high-end lithography tool. As discussed above, we entered into a lease agreement for the related equipment in the first quarter of fiscal 2021.

In the fourth quarter of fiscal 2019, the Company’s board of directors authorized the repurchase of up to $100 million of its common stock, pursuant to a repurchase plan under Rule 10b5-1 of the Securities Act. We repurchased 2.5 million shares, at a cost of $27.9 million (an average price of $11.34 per share), under this authorization. All shares repurchased during fiscal 2019 (0.9 million) were retired in fiscal 2019; the repurchase program was terminated on March 20, 2020.

### Results of Operations

### Three-Months ended January 31, 2021

The following table presents selected operating information expressed as a percentage of revenue. The columns may not foot due to rounding.

|  | Three Months Ended January 31, 2021 | October 31, 2020 | February 2, 2020 |
| --- | ---: | ---: | ---: |
| Revenue | 100.0% | 100.0% | 100.0% |
| Cost of goods sold | 79.9 | 78.6 | 78.3 |
| Gross margin | 20.1 | 21.4 | 21.7 |
| Selling, general and administrative expenses | 9.2 | 8.6 | 8.9 |
| Research and development expenses | 3.1 | 2.8 | 2.6 |
| Operating income | 7.7 | 10.0 | 10.2 |
| Other income (expense), net | 0.4 | (1.9) | 2.3 |
| Income before income tax provision | 8.2 | 8.1 | 12.5 |
| Income tax provision | 1.9 | 2.3 | 5.7 |
| Net income | 6.3 | 5.8 | 6.8 |
| Net income attributable to noncontrolling interests | 1.0 | 1.5 | 0.4 |
| Net income attributable to Photronics, Inc. shareholders | 5.3% | 4.3% | 6.4% |

Note: All the following tabular comparisons, unless otherwise indicated, are for the three-months ended January 31, 2021 (Q1 FY21), October 31, 2020 (Q4 FY20), and February 2, 2020 (Q1 FY20).

### Revenue

Our quarterly revenues can be affected by the seasonal purchasing practices of our customers. As a result, demand for our products is typically reduced during the first, and sometimes the second, quarters of our fiscal year, by the North American, European, and Asian holiday periods, as some of our customers reduce their development and, consequently, their buying activities during those periods.

The following tables present changes in disaggregated revenue in Q1 FY21 from revenue in prior reporting periods. Columns may not total due to rounding.

#### Quarterly Changes in Revenue by Product Type

| IC | Q1 FY21 from Q4 FY20 Revenue in Q1 FY21\* | Increase (Decrease) | Percent Change | Q1 FY21 from Q1 FY20 Increase (Decrease) | Percent Change |
| --- | ---: | ---: | ---: | ---: | ---: |
| High-end \* | $36.8 | $(1.4) | (3.6)% | $(4.3) | (10.4)% |
| Mainstream | 68.2 | 0.4 | 0.6% | 2.2 | 3.4% |
| Total IC | $105.0 | $(1.0) | (0.9)% | $(2.0) | (1.9)% |
| FPD |  |  |  |  |  |
| High-end \* | $34.6 | $3.3 | 10.7% | $(5.1) | (12.9)% |
| Mainstream | 12.5 | 0.4 | 3.4% | (0.5) | (4.0)% |
| Total FPD | $47.1 | $3.7 | 8.6% | $(5.6) | (10.7)% |
| Total Revenue | $152.1 | $2.8 | 1.9% | $(7.7) | (4.8)% |

25

\* High-end photomasks typically have higher average selling prices (ASPs) than mainstream products.

#### Quarterly Changes in Revenue by Geographic Origin

|  | Q1 FY21 from Q4 FY20 Revenue in Q1 FY21 | Increase (Decrease) | Percent Change | Q1 FY21 from Q1 FY20 Increase (Decrease) | Percent Change |
| --- | ---: | ---: | ---: | ---: | ---: |
| Taiwan | $56.6 | $0.0 | (0.1)% | $(9.5) | (14.4)% |
| Korea | 38.8 | 2.2 | 6.1% | (2.0) | (4.8)% |
| United States | 26.6 | (0.1) | (0.3)% | 1.5 | 6.1% |
| China | 21.0 | 0.0 | 0.0% | 1.1 | 5.5% |
| Europe | 8.6 | 0.6 | 8.0% | 1.0 | 13.7% |
| Other | 0.5 | 0.0 | 10.4% | 0.1 | 37.8% |
|  | $152.1 | $2.8 | 1.9% | $(7.7) | (4.8)% |

Revenue increased 1.9% in Q1 FY21, compared with Q4 FY20, as FPD demand rose 8.6%, primarily due to increased demand for AMOLED masks for new mobile displays. The increased demand was primarily the result of alternative phone manufacturers filling the void that resulted from the U.S. Department of Commerce adding non-U.S. affiliates of Huawei Technologies Co., Ltd. to the prohibited entity list. The growth in AMOLED demand was somewhat offset by weaker demand for LCD masks, including G10.5+, as panel producers delayed releasing new designs, and focused on meeting favorable market trends with current products. IC revenue fell just under 1% from last quarter, as a result of decreased demand for high-end logic masks; this decline was somewhat mitigated by increased demand for high-end memory and mainstream masks. In addition, the productivity loss of a high-end lithography tool contributed to the decrease in IC revenue, as the tool repair was delayed as a result of vendor imposed travel restrictions.

Revenue decreased 4.8% in Q1 FY21, compared with Q1 FY20; IC demand declined 1.9%, due to weakened demand for high-end logic photomasks, while FPD demand fell 10.7%, primarily due to lower demand for G10.5+ displays, partially offset by an increase in demand for mobile display masks.

### Gross Margin

|  | Three Months Ended Q1 FY21 | Q4 FY20 | Percent Change | Q1 FY20 | Percent Change |
| --- | ---: | ---: | ---: | ---: | ---: |
| Gross profit | $30.5 | $31.9 | (4.3)% | $34.6 | (11.8)% |
| Gross margin | 20.1% | 21.4% |  | 21.7% |  |

Gross margin decreased by 1.3 percentage points in Q1 FY21, from Q4 FY20, primarily due to unfavorable product mix; as a result, material costs increased 1.3% as a percentage of revenue, with increases experienced in all regions, excepting the U.S. Labor costs also increased as a percentage of revenue, though at a more modest 0.8 percentage points, with the largest increases experienced in the U.S. and at our two Asia based joint ventures. These increases were partially mitigated by the 1.9% increase in revenue, and a 0.8 percentage point decrease in overhead costs, as a percentage of revenue.

Gross margin decreased by 1.6 percentage points in Q1 FY21, from Q1 FY20, primarily as a result of the 4.8% decrease in revenue in the current year quarter. Materials and labor costs both increased as a percent of revenue, rising 0.6 and 1.3 percentage points, respectively, thus contributing to the decreased gross margin. Overhead costs were down 0.3 percentage points to revenue from the prior year quarter.

### Selling, General and Administrative Expenses

Selling, general and administrative expenses were $14.1 million in Q1 FY21, compared with $12.8 million in Q4 FY20, and $14.2 million in Q1 FY20. The increase from Q4 FY20 was primarily the result of increased compensation and related expenses of $0.7 million; the balance of the net increase was spread across sundry expense categories. The decrease from the prior year quarter was the result of decreased travel expenses of $0.3 million, which were partially offset by increases in sundry expense categories, none of which were individually significant.

### Research and Development Expenses

Research and development expenses consist of development efforts related to high-end process technologies for high-end IC and FPD applications, and were $4.7 million in Q1 FY21, compared with $4.1 million in both Q4 FY20 and Q1 FY20. The increase in the current quarter from both comparative quarters was primarily the result of increased development activities in the U.S.

### Other Income (Expense)

|  | Three Months Ended Q1 FY21 | Q4 FY20 | Q1 FY20 |
| --- | ---: | ---: | ---: |
| Foreign currency transactions (losses) gains, net | $1.4 | $(2.2) | $4.7 |
| Interest expense | (0.8) | (0.8) | (1.8) |
| Interest income and other income, net | 0.1 | 0.1 | 0.8 |
| Other income (expense) | $0.7 | $(2.9) | $3.7 |

The favorable change in Other income (expense), net of $3.6 million, from a net expense of $2.9 million in Q4 FY20, to net income of $0.7 million in Q1 FY21, was primarily due to $3.8 million less unfavorable foreign currency exchange losses of the South Korean won against the U.S. dollar. The decrease in Other income (expense), net of $3.0 million, from net income of 3.7 million in Q1 FY20 to $0.7 million in Q1 FY21, was primarily attributable to the effect of our recognizing $2.1 million of net foreign currency exchange gains of the South Korean won against the U.S. dollar, in Q1 FY20, compared with our recognizing $2.1 million of net foreign currency exchange losses between those same currencies in Q1 FY21. The $4.2 million net unfavorable results of the South Korean won against the U.S. dollar were partially offset by a favorable net change in results between the RMB and the U.S. dollar, which increased by $2.5 million from $2.5 million in Q1 FY20 to $5.0 million in Q1 FY21. Year-over-year interest expense decreased by $1 million, from $1.8 million in Q1 FY20 to $0.8 million in Q1 FY21, primarily as a result of interest we recorded on our loans in China. The majority of the interest on our China-based debt is eligible for reimbursements through subsidies, which we recognize upon receipt.

### Income Tax Provision

|  | Three Months Ended Q1 FY21 | Q4 FY20 | Q1 FY20 |
| --- | ---: | ---: | ---: |
| Income tax provision | $2.9 | $3.5 | $9.1 |
| Effective income tax rate | 23.6% | 28.8% | 45.4% |

The effective income tax rate is sensitive to the jurisdictional mix of earnings, due, in part, to the non-recognition of tax benefits on losses in jurisdictions with valuation allowances, where the tax benefit of the losses is not available.

The effective income tax rate decrease in Q1 FY21, compared with Q4 FY20, is primarily due to an increase in credits in a non-US jurisdiction in Q1 FY21.

The effective income tax rate decrease in Q1 FY21, compared with Q1 FY20, is primarily due to an increase in credits in a non-US jurisdiction in Q1 FY21, and the establishment of a valuation allowance for a non-U.S. based loss carryforward in Q1 FY20.

### Net Income Attributable to Noncontrolling Interests

Net income attributable to noncontrolling interests was $1.5 million in Q1 FY21, as compared with $2.1 million in Q4 FY20, and was primarily the result of decreased net income at our Taiwan-based IC facility. Net income attributable to noncontrolling interests increased $0.8 million in Q1 FY21 from $0.6 million in Q1 FY20; the net increase was attributable to a decreased loss at our China-based IC facility, which was partially offset by decreased income at our Taiwan-based IC facility.

### Liquidity and Capital Resources

We had cash and cash equivalents of $278.5 million at the end of Q1 FY21, compared with $278.7 million at the end of fiscal 2020. The net decrease of $0.1 million is primarily attributable to:

- $26.3 million provided by operating activities;
- $6.2 million received from borrowings in China;
- $17.5 million paid for property, plant, and equipment;
- $13.2 million used to repurchase our common stock;
- $7.8 million repayments of debt;
- $5.2 million positive effects of currency rate changes on our cash.

Our working capital at the end of Q1 FY21 was $360.6 million, compared with $357.2 million at the end of fiscal 2020. The $3.4 million net increase is primarily attributable to the following increases (decreases) in working capital:

- Increased accounts receivable of $5.2 million, the predominance of which arose at our Korea-based facility, as a result of a comparative late-in-the-quarter increase in shipments to Korean customers, and at our Taiwan-based IC facility, as a result of increased shipments to two China-based customers;
- Increased current portion of long-term debt of $(8.0) million, which was primarily the result of a new $6.2 million borrowing in China;
- Decreased accounts payable of $4.5 million, $3.8 million of which was the result of a reduction in payables for capital assets;
- Increased value added taxes receivable of $2.0 million.

The net cash provided by operating activities of $26.3 million in Q1 FY21 was a $4.5 million decrease from $30.8 million provided in Q1 FY20. The net decrease was due primarily to the following:

- Decreased net income of $1.4 million in Q1 FY21;
- Decreased non-cash add backs to net income, including depreciation, share-based compensation and deferred income taxes of $3.1 million;
- Cash positive comparative changes in our accounts receivable balances of $4.7 million, which primarily resulted from changes in the accounts receivable balances at our China-based sites, which commenced operations in fiscal 2019;
- A comparative increase in value added tax prepayments of $3.9 million (predominantly arising in China), and a comparative decrease in value added tax payables of $3.8 million;
- A comparative decrease in inventory growth of $3.5 million, primarily experienced in the U.S. and Korea.

Net cash used in investing activities was $17.2 million in Q1 FY21, an increase of $5.7 million from the $11.5 million used in Q1 FY20. The net increase was primarily attributable to increased capital expenditures of $3.7 million, and decreased government incentives received of $2.0 million.

Net cash flows used in financing activities increased from funds used of $7.6 million in Q1 FY20 to $14.4 million used in Q1 FY21. Significant components of the $6.7 million net increase were:

- $5.1 million increased proceeds from debt;
- $(2.2) million increased purchases of treasury stock;
- $(7.4) million increase in debt repayments;
- $(2.1) million less proceeds received from share-based arrangements.

As of January 31, 2021 and October 31, 2020, our total cash and cash equivalents included $197.8 million and $218.0 million, respectively, held by our foreign subsidiaries. The majority of earnings of our foreign subsidiaries are considered to be indefinitely reinvested. Repatriation of these funds to the U.S. may subject them to U.S. state income taxes and local country withholding taxes in certain jurisdictions. Furthermore, our foreign subsidiaries continue to grow through the reinvestment of earnings in additional manufacturing capacity and capability, particularly in the high-end IC and FPD areas.

Since we operate in a high fixed cost environment, our liquidity is highly dependent on our revenue, cash conversion cycle, and the timing of our capital expenditures (which can vary significantly from period to period). We believe that our cash on hand, cash generated from operations, and amounts available to borrow will be sufficient to meet our cash requirements for the next twelve months. However, depending on conditions in the semiconductor and display markets, our cash flows from operations and current holdings of cash may not be adequate to meet our current and long-term needs for capital expenditures, operations and debt repayments. Historically, in certain years, we have used external financing to fund these needs. Due to conditions in the credit markets and covenant restrictions on our existing debt, some financing instruments we have used in the past may not be available to us when required. Consequently, we cannot assure that additional sources of financing would be available to us on commercially favorable terms, should our long-term cash requirements exceed our existing cash and cash available under our corporate credit agreement (which is discussed in Note 6 to the condensed consolidated financial statements). Please also refer to Financing Related Risk Factors in our fiscal 2020 annual report on Form 10-K.

As of January 31, 2021, we had outstanding capital commitments of approximately $69 million. We intend to finance our capital expenditures with our working capital, contributions from our joint venture partners, cash generated from operations and, if necessary, additional borrowings.

### Off-Balance Sheet Arrangements

In January 2018, Photronics, through its wholly owned Singapore subsidiary, and DNP, through its wholly owned subsidiary “DNP Asia Pacific PTE, Ltd.” entered into a joint venture under which DNP obtained a 49.99% interest in our IC business in Xiamen, China. The joint venture, known as “Xiamen American Japan Photronics Mask Co., Ltd.” (“PDMCX”), was established to develop and manufacture photomasks for leading edge and advanced generation semiconductors. Under the joint venture’s operating agreement, DNP is afforded, under certain circumstances, the right to put its interest in PDMCX to Photronics. These circumstances include disputes regarding the strategic direction of PDMCX that may arise after the initial two-year term of the Agreement that cannot be resolved between the two parties. As of the date of issuance of this report, DNP had not indicated its intention to exercise this right. In addition, both Photronics and DNP have the option to purchase, or put, their interest from, or to, the other party, should their ownership interest fall below 20% for a period of more than six consecutive months. Under all such circumstances, the sales of ownership interests would be at the exiting party’s ownership percentage of the joint venture’s net book value, with closing to take place within three business days of obtaining required approvals and clearance. Should DNP exercise an option to put their, or purchase our, interest in PDMCX we may, depending on the relationship of the fair and book value of PDMCX’s net assets, incur a loss. As of January 31, 2021, Photronics and DNP each had net investments in PDMCX of $56.8 million.

### Business Outlook

While we, as always, caution that our outlook, due to our short backlog (which typically does not exceed two weeks) is limited, we reaffirm our Q4 FY20 expectation for revenue to increase, as a percentage of FY20 revenue, in the high single digits. We also continue to anticipate that operating profit will grow at a rate similar to the 23% increase we experienced in FY20. The bases of our expectations include growth for both IC and FPD in FY2021. IC growth drivers include added capacity across our global operations including the completion of Phase 1 of our China IC facility ramp (which we expect to begin generating revenue in Q2 FY21, and to ramp up over the succeeding quarters), growing demand for semiconductor masks in China, a recovery in high-end IC logic, continued strength in mainstream IC, and increased demand in the IC memory space. For FPD, we expect the increased demand for AMOLED displays to continue throughout the year; this, along with the expected transition from LCD to OLED displays, or alternative advanced screen technologies, for ultra-large screen TVs will result in increased demand for more critical layer photomasks, consequently increasing our FPD revenue. To support this foreseen increase in demand for high-end display masks, we have invested in three additional FPD write tools. We are also encouraged by the widening availability of recently developed coronavirus vaccines, as we think this supports a reasonable expectation that supply chain disruptions and travel restrictions will continue to be eased over the next several quarters, concomitantly reducing the impediments to growth they represented in FY20.

The impact, if any, on our business of changing geopolitical conditions, such as U.S.-China trade relations, tensions between the Republic of South Korea and Japan, and the effects of the United Kingdom exiting the European Union cannot be predicted. However, we believe the recent change in leadership in the U.S. may lead to an improvement in its trade relationship with China, including the possible removal of sanctions on some Chinese enterprises, as well as a reduction in the likelihood of the impositions of additional sanctions.

We believe that a majority of the growth in the IC and FPD markets will come from the Asia region, predominantly in China. We expect to meet these demands both through the utilization of our facilities in China and by importing photomasks into China from our other facilities. We make continual assessments of our global manufacturing strategy and monitor our revenue and related cash flows from operations. These ongoing assessments could result in future facility closures, asset redeployments, impairments of intangible or long-lived assets, workforce reductions, or the addition of manufacturing facilities, all of which would be based on market conditions and customer requirements.

### Effect of Recent Accounting Pronouncements

See “Item 1. Condensed Consolidated Financial Statements– Notes to Condensed Consolidated Financial Statements – Note 16 – Recent Accounting Pronouncements” for recent accounting pronouncements that may affect the Company’s financial reporting.

## Market risk

As filed, 3,279 characters.

### Foreign Currency Exchange Rate Risk

We conduct business in several major international currencies throughout our worldwide operations, and our financial performance may be affected by fluctuations in the exchange rates of these currencies. Changes in exchange rates can positively or negatively affect our reported revenue, operating income, assets, liabilities, and equity. The functional currencies of our Asian subsidiaries are the South Korean won, the New Taiwan dollar, the Chinese renminbi, and the Singapore dollar. The functional currencies of our European subsidiaries are the British pound and the euro. In addition, we engage in transactions in, and have exposures to, the Japanese yen.

We attempt to minimize our risk of foreign currency transaction losses by producing products in the same country in which the products are sold (thereby generating revenues and incurring expenses in the same currency), and by managing our working capital. However, in some instances, we sell products in a currency other than the functional currency of the country where it was produced, or purchase products in a currency that differs from the functional currency of the purchasing entity. In addition, to the extent practicable, we attempt to reduce our exposure to foreign currency exchange fluctuations by converting cash and cash equivalents into the functional currency of the subsidiary which holds the cash. We may also enter into derivative contracts to mitigate our exposure to foreign currency fluctuations when we have a significant purchase obligation, or a significant receivable denominated in a currency that differs from the functional currency of the transacting subsidiary. We do not enter into derivatives for speculative purposes. There can be no assurance that this approach will protect us from the need to recognize significant foreign currency transaction gains and losses, especially in the event of a significant adverse movement in the value of any foreign currency in which we conduct business against any of our functional currencies, including the U.S. dollar.

Our primary net foreign currency exposures as of January 31, 2021, included the South Korean won, the Japanese yen, the New Taiwan dollar, the Chinese renminbi, the Singapore dollar, the British pound sterling, and the euro. As of that date, a 10% adverse movement in the value of currencies different than the functional currencies of our subsidiaries would have resulted in a net unrealized pre-tax loss of $32.5 million, which represents an increase of $0.6 million from our exposures at October 31, 2020. Our most significant exposures at January 31, 2021, related to both the Chinese renminbi and the South Korean won exposures to the U.S. dollar, which were $12.6 million and $11.8 million, respectively, at that date. We do not believe that a 10% change in the exchange rates of non-US dollar currencies, other than the aforementioned currencies and the Japanese Yen, would have had a material effect on our January 31, 2021, condensed consolidated financial statements.

### Interest Rate Risk

A 10% adverse movement in the interest rates on our variable rate borrowings would not have had a material effect on our January 31, 2021 condensed consolidated financial statements.

## Controls and procedures

As filed, 3,270 characters.

### Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our chief executive officer and chief financial officer, evaluated the effectiveness of our disclosure controls and procedures as of January 31, 2021. We have established and currently maintain disclosure controls and procedures, as such term is defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), designed to provide reasonable assurance that information required to be disclosed in our reports filed under the Exchange Act, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission's rules and forms, and that such information is accumulated and communicated to management, including our chief executive officer and chief financial officer, as appropriate, to allow for timely decisions regarding required disclosure. In designing and evaluating disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on an evaluation of our disclosure controls and procedures as of January 31, 2021, our chief executive officer and chief financial officer concluded that, as of such date, our disclosure controls and procedures were not effective due to a material weakness in our internal control over financial reporting as discussed below.

Based on our prior assessment as of October 31, 2020, management concluded that our internal control over financial reporting was not effective due to a material weakness relating to the accuracy and completeness of information used in monitoring compliance with covenants stipulated by the Company’s debt agreements. This material weakness has not been remediated as of January 31, 2021.

Notwithstanding this material weakness, our management, including our chief executive officer and chief financial officer, has concluded that our financial statements included in this Quarterly Report on Form 10-Q present fairly, in all material respects, our financial position, results of operations and cash flows for the periods presented in accordance with accounting principles generally accepted in the United States of America.

### Remediation of Material Weakness

Our management is committed to maintaining a strong internal control environment and implementing measures designed to help ensure that the material weakness is remediated as soon as possible. Management is in the process of designing and implementing a remediation plan to address the material weaknesses referred to above.

### Changes in Internal Control over Financial Reporting

Except for changes made in connection with our implementation of the remediation efforts mentioned above, there have been no other changes in our internal control over financial reporting during the fiscal quarter ended January 31, 2021, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Filed Mar 10, 2021.
Source: SEC EDGAR, the filing index for accession 0001140361-21-008063. Last ingested by Listed: Nov 15, 2026, 01:00 ET. No prices; not investment advice.
